Elizabeth Gourd. Show Affiliations »
Abstract
Mesh： See more » Combined Modality TherapyDisease-Free SurvivalFemaleFranceHead and Neck Neoplasms/drug therapyHead and Neck Neoplasms/mortalityHead and Neck Neoplasms/radiotherapyHumansMalePrognosisRisk AssessmentSquamous Cell Carcinoma of Head and Neck/drug therapySquamous Cell Carcinoma of Head and Neck/mortalitySquamous Cell Carcinoma of Head and Neck/radiotherapySurvivalTreatment Outcome
Year: 2018 PMID： 29909947 DOI： 10.1016/S1470-2045(18)30452-2
Source DB: PubMed Journal: Lancet Oncol ISSN： 1470-2045 Impact factor: 41.316